4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-002177
Director sold 30,000 shares at $58.66 ($1,759,800)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KUEBLER CHRISTOPHER A Director | 2018-01-02 | Option exercise | +30,000 | $14.26 | $427,800 | 70,500 | D: show line 1 in the form |
| KUEBLER CHRISTOPHER A Director | 2018-01-02 | Sale | −30,000 | $58.66 | $1,759,800 | 40,500 | D: show line 2 in the form |
| Open-market sales · 30,000 sh · avg $58.66 · $1,759,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KUEBLER CHRISTOPHER A Director | 2018-01-02 | Option exercise · Stock Option | −30,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…